Cookies?
Library Header Image
LSE Research Online LSE Library Services

The generics paradox revisited: empirical evidence from regulated markets

Vandoros, Sotiris and Kanavos, Panos (2013) The generics paradox revisited: empirical evidence from regulated markets. Applied Economics, 45 (22). pp. 3230-3239. ISSN 0003-6846

Full text not available from this repository.

Identification Number: 10.1080/00036846.2012.703313

Abstract

Earlier studies have pointed at the presence of a generics paradox in the US prescription drug market. This article tests whether the generics paradox also holds in the presence of pricing and reimbursement regulation in six European prescription drug markets. Using proprietary pricing and market share data, the results of panel data analysis suggest that the generics paradox also holds in these markets. Neither generic entry nor generic market penetration affect prices of originator drugs downwards, and prices of originator drugs actually increase post-generic entry.

Item Type: Article
Official URL: http://www.tandfonline.com/loi/raec20
Additional Information: © 2012 Taylor & Francis Group
Subjects: H Social Sciences > HC Economic History and Conditions
R Medicine > RM Therapeutics. Pharmacology
Sets: Departments > European Institute
Departments > Social Policy
Research centres and groups > LSE Health
Date Deposited: 13 Jul 2012 13:15
Last Modified: 31 Aug 2012 10:07
URI: http://eprints.lse.ac.uk/id/eprint/44854

Actions (login required)

View Item View Item